Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G6AB
|
|||
| Former ID |
DNAP001636
|
|||
| Drug Name |
Monocrotaline
|
|||
| Synonyms |
monocrotaline; 315-22-0; Crotaline; Monocrotalin; NSC 28693; CCRIS 416; (-)-Monocrotaline; UNII-73077K8HYV; HSDB 3513; Retronecine cyclic 2,3-dihydroxy-2,3,4-trimethylglutarate; BRN 0048732; (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione; CHEBI:6980; 14,19-Dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione; QVCMHGGNRFRMAD-XFGHUUIASA-N; 73077K8HYV; 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13alpha,14alpha)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H23NO6
|
|||
| Canonical SMILES |
CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O
|
|||
| InChI |
1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1
|
|||
| InChIKey |
QVCMHGGNRFRMAD-XFGHUUIASA-N
|
|||
| CAS Number |
CAS 315-22-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
12536, 598417, 8149867, 8156735, 10321395, 11336134, 11361373, 11364118, 11366680, 11369242, 11372113, 11374493, 11377404, 11462345, 11466631, 11467751, 11484488, 11486461, 11488722, 11490762, 11492871, 11495038, 11533634, 11537696, 14801630, 24892326, 26612358, 26680226, 26757673, 29204410, 29228009, 47365283, 47440352, 47589069, 47662376, 47885491, 48035215, 48110527, 48110528, 48185068, 48414072, 48423729, 49698578, 49857509, 50124254, 50124255, 51003411, 56463109, 57325639, 81093012
|
|||
| ChEBI ID |
CHEBI:6980
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.